Antimicrobial resistance

Did you know that in the United States alone someone gets an antibiotic-resistant infection every 11 seconds, and every 15 minutes someone dies as a result? That means people are dying of infections that are no longer responding to the drugs designed to kill them. This new data comes from CDC’s recently released Antibiotic Resistance Threats in the United States, 2019 showing that antibiotic-resistant pathogens are causing more than 2.8 million infections and 35,000 deaths across the U.S. As the report shows, too many people are still affected by resistant infections, many of which are preventable. The world can do more to prevent these infections and to stop the spread of pathogens across...
Dear Research Advocate, It’s Halloween! I was astonished to learn that Americans will spend some $9 billion on candy, costumes and decorations this year. $9 billion would fund: NIH’s National Institute on Dental and Craniofacial Research for more than 27 years; CDC’s Vaccines for Children program for almost two and a half years; FDA’s Foods program for eight and a half years; or NSF’s entire budget for more than one year. These comparisons (and you can imagine many more like them) aren’t meant to disparage a fun holiday, but rather to underscore that investing in life-saving medical and public health research is affordable for this wealthy nation of ours — in fact, it’s a relatively small...
The fall 2019 edition of Research!America's newsletter, the Research Advocate, is now online ! Among the articles in this issue: Advocacy Award Recipients Announced The 24th annual Research!America Advocacy Awards, to be held at the Andrew W. Mellon Auditorium in Washington, D.C. on March 11, 2020, brings together leaders from government, industry, academia, patient groups, scientific societies, independent research institutes, and health advocacy organizations to honor exceptional advocates for research. Earlier this month, Research!America announced the first round of recipients for many of the awards. Bruce M. Alberts, PhD , former president (1993-2005) of the National Academy of...
Dear Research Advocate, As part of the U.S. Chamber of Commerce’s launch of Civics Forward , CEO Thomas Donahue challenged the business community to play a leading role in civic education, for no less a reason than assuring the future of our nation. This challenge is reminiscent of his call to the science community last February at the AAAS meeting to do more with the business community, in order to achieve shared aspirations. As he said at the time, “without science there is no innovation, and without innovation, there is no industry,” going on to emphasize the enduring value the business community accords to science. There is no question that heightened attention to civic education and...
Dear Research Advocate, Our guest author this week is Ellie Dehoney, Research!America’s Vice President of Policy and Advocacy. Ten years ago this month, Dr. Francis Collins became the 16th Director of the National Institutes of Health. The Ad Hoc Group for Medical Research, of which Research!America is a member, sent a letter to Dr. Collins congratulating and thanking him for his remarkable service, achievements and impact. Our latest web resource highlights the history, progress, and promise of the groundbreaking research NIH conducts and supports. Funding for NIH and our nation’s other science agencies hinges on timely congressional action, and on you. Don’t wait to advocate. Hard-won...
This is the fourth installment in a blog series about awareness of antibacterial resistance in recognition of World Antibiotic Awareness Week, November 12-18, 2018. Check back for more blog posts soon! Which of our interventions, devices, and cures could save lives from antimicrobial resistance (AMR)? What roadblocks are keeping us from making the next groundbreaking discovery to combat AMR? What investments would stop its spread? Over the next year, the U.S. Centers for Disease Control and Prevention (CDC), along with the U.S. Department of Health and Human Services, is asking leaders around the world to commit to action in one of these areas and join The AMR Challenge . We need your help...
Nearly two thirds of Americans (65%) say antibiotic resistance is a public health problem and a strong majority (81%) say they are concerned that antibiotic resistance will make more infections difficult or impossible to treat and even deadly, according to a national public opinion survey commissioned by Research!America in collaboration with the Infectious Disease Society of America (IDSA). The survey was supported in part by Pfizer Inc. Majorities across the political spectrum say the federal government should increase funding for research and public health initiatives to address antibiotic resistance – specifically 81% of Democrats, 76% of Republicans and 70% of Independents. “Americans...
A global solution and removing barriers to antibiotic development are necessary to combat antimicrobial resistance (AMR). Representatives from various research and health sectors discussed strategies for fighting superbugs at a BIO International Convention super session today. The panel agreed there must be a greater focus on streamlining clinical trials and harmonizing the global regulatory process to support the development of new antibiotics. Jim O'Neill, chairman, Review on Antimicrobial Resistance, recommended the establishment of a global $2 billion AMR Innovation Fund over five years funded by industry to help jump start product development. Venture capitalist risk could stimulate...
The serendipitous discovery of penicillin by Alexander Fleming in 1928 transformed the course of modern medicine. Penicillin, followed by a series of other antibiotics, seemed to promise a world free of infectious diseases that once killed millions of people worldwide. Medical breakthroughs such as organ transplants and chemotherapy would not have been possible without the development of antimicrobials. Fleming warned, however, that microbes have the ability to, and inevitably will, develop resistance to antibiotics. It did not take long to prove him right, with drug-resistant strains appearing just within years after the introduction of penicillin, as was the case for many subsequent...